跳至主要内容
临床试验/PACTR202310744034060
PACTR202310744034060尚未招募3 期

Safety And Efficacy Of Sublingual Versus Vaginal Misoprostol For Labour Induction Among Primigravida At Term: A Randomised Controlled Trial

Dr. Aituma Lewis Osadebamwen0 个研究点目标入组 82 人开始时间: 2023年9月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Gestational age =37 to 42 weeks.
  • Participants who have indication for induction of Labour.
  • Cervical assessment with Modified Bishops score value of less than 6.
  • Singleton gestation.
  • Cephalic presentation.
  • Optimal biophysical profile.
  • Participants who gave written consent to participate in the study.

排除标准

  • Teenage pregnancy.
  • Participants who withdraw consent even after being enrolled into the sudy.
  • All indications for Cesarean section.
  • Participants with relative or absolute contraindications to misoprostol use (e.g.; misoprostol allergies, Acute Cerebrovascular Disease, Coronary Artery Disease, epileptics).
  • A history of extensive uterine surgery.
  • Abnormal vaginal bleeding.
  • An unconscious patient.

研究者

发起方
Dr. Aituma Lewis Osadebamwen

相似试验